Categories Uncategorized

DGE’s 2-Day Omnichannel Marketing Strategy Symposium To Offer Skills To Elevate Customized Consumer Experience

Live Streaming Event

June 10th-11th 2021

On June 10-11, 2021, life science professionals are invited to attend DGE’s Omnichannel Marketing Strategy Symposium to learn skills and techniques for developing a personalized marketing strategy for consumers. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

As marketing gets personalized and consumers expect to be reached on their channel of preference, pharma companies are spending significantly on marketing and sales. But, do all pharma companies have the technology? And are their marketing campaigns as successful as they should be?

This omnichannel marketing event aims to allow pharma companies to reach the right people, at the right time, and with the right message. While most pharma companies admit that they lack the resources to offer personalized consumer plans, they realize that personalization is the key to grab user attention. And with the changing landscape of the pharma arena owing to the COVID-19 impact, marketing strategies need to be revised and updated. 

The event will present 17 World-Class speakers from the pharma and life science fraternity who will share their opinions and knowledge on omnichannel marketing. These eminent personalities will discuss the benefits of omnichannel marketing and explain to the attendees how integrating omnichannel processes will result in a stronger customer experience, increased brand awareness, improved insights, and high customer engagements and conversions. 

Top reasons to attend:

  • Innovative yet scalable strategies for identifying demographics for personalized messaging 
  • Updated ways of adapting and promoting an omnichannel marketing approach 
  • Case studies on tracking and improving HCP engagement through digital interactions
  • Clarity on the revised roles of sales representatives in the changing COVID-19 scenario

This Omnichannel Marketing Strategy Symposium is the only life science event devoted to this industry that is being streamed live on a proven successful interactive platform. Omnichannel marketing offers a seamless consumer experience and is the future of life science marketing. The agenda of this online live streaming symposium is to educate life science professionals to plan and successfully implement strategies for better consumer engagement and conversions.

To know more about the event, please visit https://ibn.fm/7g3wP

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in…

1 day ago

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential…

3 days ago

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…

3 days ago

Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Transformative Partnerships Formed in Growing Pharma Sector

Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…

4 days ago

Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care

Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…

1 week ago

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…

1 week ago